Tocqueville Asset Management’s Champions Oncology CSBR Stock Holding History

Tocqueville Asset Management’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.82M	Sell	295,658 -24,016	-8%	-$145K	0.02%	311
2026 Q1	$1.84M	Hold	319,674	–	–	0.03%	300
2025 Q4	$2.21M	Hold	319,674	–	–	0.03%	297
2025 Q3	$2.07M	Sell	319,674 -80,208	-20%	-$565K	0.03%	296
2025 Q2	$2.95M	Hold	399,882	–	–	0.04%	255
2025 Q1	$3.47M	Sell	399,882 -209,033	-34%	-$2.12M	0.06%	217
2024 Q4	$5.22M	Sell	608,915 -96,299	-14%	-$485K	0.08%	179
2024 Q3	$3.43M	Buy	705,214 +20,586	+3%	+$96.5K	0.05%	216
2024 Q2	$3.54M	Hold	684,628	–	–	0.06%	210
2024 Q1	$3.35M	Buy	684,628 +50	+0%	+$293	0.05%	220
2023 Q4	$3.85M	Buy	684,578 +19,150	+3%	+$107K	0.07%	199
2023 Q3	$4.13M	Hold	665,428	–	–	0.08%	190
2023 Q2	$4.25M	Hold	665,428	–	–	0.08%	198
2023 Q1	$2.68M	Buy	665,428 +50,200	+8%	+$215K	0.05%	241
2022 Q4	$2.77M	Buy	615,228 +273,562	+80%	+$1.79M	0.05%	248
2022 Q3	$2.56M	Buy	341,666 +55,055	+19%	+$460K	0.05%	252
2022 Q2	$2.29M	Buy	286,611 +34,150	+14%	+$261K	0.04%	300
2022 Q1	$2.05M	Hold	252,461	–	–	0.03%	337
2021 Q4	$2.11M	Hold	252,461	–	–	0.03%	370
2021 Q3	$2.58M	Hold	252,461	–	–	0.04%	332
2021 Q2	$2.6M	Hold	252,461	–	–	0.04%	342
2021 Q1	$2.85M	Hold	252,461	–	–	0.04%	325
2020 Q4	$2.72M	Hold	252,461	–	–	0.05%	311
2020 Q3	$2.33M	Hold	252,461	–	–	0.04%	291
2020 Q2	$2.41M	Hold	252,461	–	–	0.05%	279
2020 Q1	$1.87M	Buy	252,461 +47,893	+23%	+$335K	0.05%	281
2019 Q4	$1.7M	Buy	204,568 +70,000	+52%	+$432K	0.03%	373
2019 Q3	$760K	Buy	134,568 +55,000	+69%	+$357K	0.01%	491
2019 Q2	$623K	Hold	79,568	–	–	0.01%	553
2019 Q1	$779K	Hold	79,568	–	–	0.01%	510
2018 Q4	$621K	Sell	79,568 -10,000	-11%	-$115K	0.01%	524
2018 Q3	$1.56M	Sell	89,568 -25,383	-22%	-$226K	0.02%	439
2018 Q2	$729K	Buy	+114,951	New	+$553K	0.01%	555

Other funds holding CSBR

BMC

Battery Management Corp Boston, Massachusetts $368M AUM 28.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Tocqueville Asset Management's CSBR Position: Q2 2026 in Review

Tocqueville Asset Management reduced its Champions Oncology (CSBR) stake by 7.5% in Q2 2026, selling an estimated $145K and leaving 295,658 shares worth $1.82M. The position accounts for 0.02% of the portfolio, ranked #311.

Tocqueville Asset Management first reported a position in CSBR in Q2 2018 and has held it in 33 quarters since. The position peaked at $5.22M in Q4 2024. 28 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

Tocqueville Asset Management held 295,658 shares of Champions Oncology worth $1.82M as of Q2 2026.
Tocqueville Asset Management sold 24,016 Champions Oncology shares in Q2 2026, an estimated $145K.
Champions Oncology made up 0.02% of Tocqueville Asset Management's portfolio in Q2 2026, its #311 holding.
Tocqueville Asset Management first reported a position in Champions Oncology in Q2 2018 and has held it in 33 quarters since.
Tocqueville Asset Management's Champions Oncology position peaked at $5.22M in Q4 2024.
28 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.